Announcements
Eurosurveillance remains in the updated list of the Directory of Open Access Journals (DOAJ). It was first added to the DOAJ on 9 September 2004. Eurosurveillance is also listed in the Securing a Hybrid Environment for Research Preservation and Access / Rights MEtadata for Open archiving (SHERPA/RoMEO) [2], a database which uses a colour‐coding scheme to classify publishers according to their self‐archiving policy and to show the copyright and open access self-archiving policies of academic journals. Eurosurveillance is listed there as a ‘green’ journal, which means that authors can archive pre-print (i.e. pre-refereeing), post-print (i.e. final draft post-refereeing) and archive the publisher's version/PDF.

ESCAIDE participants are invited to the fifth Eurosurveillance scientific seminar on 30 November 2016

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Read our articles on Zika virus infection

Read our articles on mcr-1-mediated colistin resistance

Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. Available from: http://www.eurosurveillance.org / ViewArticle.aspx?ArticleId=21169


In this issue


Home Eurosurveillance Weekly Release  2003: Volume 7/ Issue 37 Article 2
Back to Table of Contents
Previous
Next

Eurosurveillance, Volume 7, Issue 37, 11 September 2003
Articles

Citation style for this article: WHO recommendation on influenza vaccination, as a SARS precautionary measure, highlights differences in policies for healthcare workers across Europe. Euro Surveill. 2003;7(37):pii=2290. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=2290

WHO recommendation on influenza vaccination, as a SARS precautionary measure, highlights differences in policies for healthcare workers across Europe

Editorial team (eurowkly@hpa.org.uk), Eurosurveillance editorial office

The World Health Organization (WHO) has urged countries to vaccinate promptly those who are at high risk from influenza infection, such as the elderly, the immunocompromised, and those with underlying chronic disease, and to increase vaccine coverage of healthcare workers who have contact with these people (1).

WHO hopes that by reducing the number of influenza infections, and the respiratory complications, such as pneumonia, that influenza can lead to, any infections of severe acute respiratory syndrome (SARS) that may occur during the winter season will be recognised more easily and diagnosed earlier.

A recent paper (2) shows influenza vaccination recommendations in 50 countries in 2000, and the Table below shows these recommendations in the countries of the European Union (EU). When the data was collected, a few countries did not recommend vaccination of healthcare workers.

Table. Influenza vaccination recommendations and vaccine utilisation in EU countries in 2000. Source: adapted from reference 2.

Countries Age >High risk conditions * Other Other target groups Vaccine doses per 1000 population
HIV Children on long term aspirin Pregnancy Nursing home residents Healthcare workers Household contacts
Austria 60 Yes - - - Yes Yes Yes 135
Belgium 65 Yes Yes Yes Yes Yes Yes Yes 170
Denmark 65 Yes Yes - - Yes - - 115
Finland 65 Yes - Yes - - - - 101
France 65 Yes Yes Yes - Yes Yes - 177
Germany 60 Yes Yes - - Yes Yes - 186
Greece 65 Yes Yes - - - Yes Yes 124
Ireland 65 Yes Yes Yes - Yes Yes Yes 140
Italy 65 Yes Yes Yes - Yes Yes Yes 156
Netherlands 65 Yes Yes Yes - Yes - - 197
Norway 65 Yes - - - Yes Yes - 96
Portugal 65 Yes - - - - - - 132
Spain 65 Yes Yes Yes - Yes Yes Yes 178
Sweden 65 Yes - - - - - - 95
United Kingdom 65 Yes Yes - - Yes Yes - 186

 

* All countries recommended vaccination for people who have chronic cardiovascular, respiratory, diabetes mellitus (except Norway), renal (except Denmark, Norway and Sweden) conditions, or who are immunocompromised for six months or longer.

References:
  1. WHO Media Centre. Amid SARS concerns, WHO urges influenza vaccinations for high-risk groups. Press release, 2 September 2003. (http://www.who.int/mediacentre/notes/2003/np22/en/) [accessed 11 September 2003]
  2. Van Essen GA, Palache AM, Forleo E, Fedson DS. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 2003; 21: 1780-5. (access at http://www.elsevier.com/locate/vaccine, subscription required)

back to top



Back to Table of Contents
Previous
Next

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN 1560-7917] - ©2007-2016. All rights reserved.
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.